.svg){kind=small}
Dr Jorg Taubel will be presenting his latest scientific poster presentation on Day 1 from 14h20 to 15h00; Investigating the effect of intravenous APD421 (Amilsulpride) and the ethnic differences between Japanese and Caucasians on cardiac conductionThe theme of this year’s meeting is "Rolling back the frontiers of clinical pharmacology and therapeutics," and its focus will be to revive the spirit of the Society’s founding days and push back the horizons of new clinical pharmacology (and therapeutics) in the 21st century.
.avif)
Latest news
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
